116 related articles for article (PubMed ID: 35839975)
1. CHO cathepsin B identified as the protease responsible for a target bispecific antibody fragmentation.
Hu L; Liu S; Xia L; Cong X; Xu C; Wang L; Li Y
Protein Expr Purif; 2022 Nov; 199():106144. PubMed ID: 35839975
[TBL] [Abstract][Full Text] [Related]
2. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.
Bee JS; Tie L; Johnson D; Dimitrova MN; Jusino KC; Afdahl CD
Biotechnol Prog; 2015; 31(5):1360-9. PubMed ID: 26259961
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of CHO host cell protease-induced fragmentation of a recombinant monoclonal antibody during production process development.
Yang B; Li W; Zhao H; Wang A; Lei Y; Xie Q; Xiong S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():1-10. PubMed ID: 30836312
[TBL] [Abstract][Full Text] [Related]
4. Sodium caprylate wash during Protein A chromatography as an effective means for removing protease(s) responsible for target antibody fragmentation.
Hu L; Tang J; Zhang X; Li Y
Protein Expr Purif; 2021 Oct; 186():105907. PubMed ID: 34022391
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D: Removal strategy on protein A chromatography, near real time monitoring and characterisation during monoclonal antibody production.
Cui T; Chi B; Heidbrink Thompson J; Kasali T; Sellick C; Turner R
J Biotechnol; 2019 Nov; 305():51-60. PubMed ID: 31442501
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin L Causes Proteolytic Cleavage of Chinese-Hamster-Ovary Cell Expressed Proteins During Processing and Storage: Identification, Characterization, and Mitigation.
Luo H; Tie L; Cao M; Hunter AK; Pabst TM; Du J; Field R; Li Y; Wang WK
Biotechnol Prog; 2019 Jan; 35(1):e2732. PubMed ID: 30320962
[TBL] [Abstract][Full Text] [Related]
7. Removing half antibody byproduct by Protein A chromatography during the purification of a bispecific antibody.
Chen X; Wang Y; Li Y
Protein Expr Purif; 2020 Aug; 172():105635. PubMed ID: 32268171
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
[TBL] [Abstract][Full Text] [Related]
9. A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture.
Wang C; Vemulapalli B; Cao M; Gadre D; Wang J; Hunter A; Wang X; Liu D
MAbs; 2018; 10(8):1226-1235. PubMed ID: 30153083
[TBL] [Abstract][Full Text] [Related]
10. Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis.
Madsen JA; Farutin V; Carbeau T; Wudyka S; Yin Y; Smith S; Anderson J; Capila I
MAbs; 2015; 7(6):1128-37. PubMed ID: 26291024
[TBL] [Abstract][Full Text] [Related]
11. Comparing the relative robustness of byproduct removal by wash and by elution in column chromatography for the purification of a bispecific antibody.
Wan Y; Zhang T; Wang Y; Li Y
Protein Expr Purif; 2021 Jan; 177():105762. PubMed ID: 32971297
[TBL] [Abstract][Full Text] [Related]
12. Identification of a host cell protein impurity in therapeutic protein, P1.
Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G
J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the power of electrophoresis and chromatography: Offline coupling of reverse phase liquid chromatography-capillary zone electrophoresis-tandem mass spectrometry for analysis of host cell proteins in monoclonal antibody producing CHO cell line.
Kumar R; Shah RL; Ahmad S; Rathore AS
Electrophoresis; 2021 Mar; 42(6):735-741. PubMed ID: 33348443
[TBL] [Abstract][Full Text] [Related]
14. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
[TBL] [Abstract][Full Text] [Related]
15. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
Huang Y; Molden R; Hu M; Qiu H; Li N
J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry.
Pilely K; Nielsen SB; Draborg A; Henriksen ML; Hansen SWK; Skriver L; Mørtz E; Lund RR
Biotechnol Prog; 2020 Jul; 36(4):e2983. PubMed ID: 32087048
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines.
Hamaker NK; Min L; Lee KH
Biotechnol Bioeng; 2022 Aug; 119(8):2221-2238. PubMed ID: 35508759
[TBL] [Abstract][Full Text] [Related]
18. Production of bispecific antibodies in "knobs-into-holes" using a cell-free expression system.
Xu Y; Lee J; Tran C; Heibeck TH; Wang WD; Yang J; Stafford RL; Steiner AR; Sato AK; Hallam TJ; Yin G
MAbs; 2015; 7(1):231-42. PubMed ID: 25427258
[TBL] [Abstract][Full Text] [Related]
19. Degradation of an Fc-fusion recombinant protein by host cell proteases: Identification of a CHO cathepsin D protease.
Robert F; Bierau H; Rossi M; Agugiaro D; Soranzo T; Broly H; Mitchell-Logean C
Biotechnol Bioeng; 2009 Dec; 104(6):1132-41. PubMed ID: 19655395
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Proteolytic Processing of ABCA3: Identification of Cleavage Site and Involved Proteases.
Hofmann N; Galetskiy D; Rauch D; Wittmann T; Marquardt A; Griese M; Zarbock R
PLoS One; 2016; 11(3):e0152594. PubMed ID: 27031696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
